EUVIMEDEUVIMED entdecken
Fallbericht

Enterococcus faecium harbouring vanA , optrA and cfr( D) on a linear plasmid in Canada: a CANWARD surveillance case

Melissa McCracken, Nicole Lerminiaux iD, Heather J Adam iD, Melanie Baxter, James A Karlowsky, George R Golding, George G Zhanel

Journal of Antimicrobial Chemotherapy · 19.01.2026 · 81 (2)

DOI: 10.1093/jac/dkaf478 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 19.01.2026. Verfasst von Melissa McCracken und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba R3E 3M4, Canada. Hauptthemen laut MEDLINE: Enterococcus faecium, Plasmids, Gram-Positive Bacterial Infections, Carbon-Oxygen Ligases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: University of Manitoba, National Microbiology Laboratory, Avir Pharma Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

VRE resistant to potential therapeutic agents such as linezolid are an increasing concern in Canada and worldwide. Infections produced by these isolates have limited treatment options and are associated with poor clinical outcomes. We report an isolate of vancomycin-resistant Enterococcus faecium (VREfm); identified through the Canadian surveillance program, CANWARD, which exhibited linezolid resistance (LVREfm); and carried the optrA and cfr(D) genes on a linear plasmid.

Methods

Antimicrobial susceptibility testing was performed by broth microdilution and MICs were interpreted by 2025 CLSI breakpoints. WGS was performed to characterize resistance determinants and the associated plasmid.

Results

In 2021, a single LVREfm isolate was recovered from a blood culture of a 67-year-old male patient admitted to an ICU. The isolate was XDR but remained susceptible dose dependent to daptomycin (MIC = 2 mg/L). MLST identified the isolate as ST817, a sequence type not commonly found in our national collection. Vancomycin resistance was mediated by the vanA gene cluster, while linezolid resistance determinants included optrA, cfr(D) and the 23S rRNA gene mutation, G2576T. Vancomycin and linezolid resistance genes were co-located on a linear plasmid that exhibited over 94% sequence identity to previously described linear plasmids from India and the USA. Notably, the plasmid also encoded four toxin–antitoxin systems, potentially contributing to its stability and persistence.

Conclusions

This case highlights the appearance of linezolid resistance in VRE mediated by linear plasmids in Canada and underscores the importance of ongoing genomic surveillance to track the dissemination of MDR determinants in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterococcus faeciumPlasmidsGram-Positive Bacterial InfectionsCarbon-Oxygen LigasesBacterial ProteinsHumansMaleCanadaMicrobial Sensitivity TestsAgedAnti-Bacterial AgentsLinezolidMultilocus Sequence TypingDrug Resistance, Multiple, BacterialVancomycin ResistanceVancomycin-Resistant EnterococciWhole Genome Sequencing

Substanzen

Anti-Bacterial AgentsLinezolidVanA ligase, BacteriaCarbon-Oxygen LigasesBacterial Proteins

Autor:innen und Institutionen

  • National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba R3E 3M4, Canada.
  • Department of Medical Microbiology/Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba R3E 0J9, Canada.
  • Clinical Microbiology, Diagnostic Services, Shared Health, MS673-820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9, Canada.

ORCID-Profile: Nicole Lerminiaux, Heather J Adam

Förderung

  • University of Manitoba
  • National Microbiology Laboratory
  • Avir Pharma Inc.
  • Iterum Therapeutics
  • Merck Canada Inc.
  • Paladin Labs
  • Pfizer
  • Sandoz Canada

Zitieren

APA

McCracken, M., Lerminiaux, N., Adam, H. J., Baxter, M., Karlowsky, J. A., Golding, G. R., & Zhanel, G. G. (2026). Enterococcus faecium harbouring vanA , optrA and cfr( D) on a linear plasmid in Canada: a CANWARD surveillance case. Journal of Antimicrobial Chemotherapy, 81(2). https://doi.org/10.1093/jac/dkaf478

Vancouver

McCracken M, Lerminiaux N, Adam HJ, Baxter M, Karlowsky JA, Golding GR, et al. Enterococcus faecium harbouring vanA , optrA and cfr( D) on a linear plasmid in Canada: a CANWARD surveillance case. Journal of Antimicrobial Chemotherapy. 2026;81(2). doi:10.1093/jac/dkaf478

BibTeX
@article{McCracken2026,
  author = {McCracken, Melissa and Lerminiaux, Nicole and Adam, Heather J and Baxter, Melanie and Karlowsky, James A and Golding, George R and Zhanel, George G},
  title = {Enterococcus faecium harbouring vanA , optrA and cfr( D) on a linear plasmid in Canada: a CANWARD surveillance case},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {2},
  doi = {10.1093/jac/dkaf478}
}
Kostenlos starten →